Skip to main content
Accessibility|Contact|Privacy|Terms of Service

Increased Risk of Muscle Injury with Zocor FDA Warns

  • Published: 2010-03-21 : Author: U.S. Food and Drug Administration
  • Synopsis: Highest approved dose of cholesterol-lowering medication could cause harm to muscles.

Main Document

FDA Warns About Increased Risk of Muscle Injury with Zocor - Highest approved dose of cholesterol-lowering medication could cause harm to muscles.

The U.S. Food and Drug Administration today warned patients and healthcare providers about the potential for increased risk of muscle injury from the cholesterol-lowering medication Zocor (simvastatin) 80 mg. Although muscle injury (called myopathy) is a known side effect with all statins, today's warning highlights the greater risk of developing muscle injury, including rhabdomyolysis, for patients when they are prescribed and use higher doses of this drug. Rhabdomyolysis is the most serious form of myopathy and can lead to severe kidney damage, kidney failure, and sometimes death.

"Review of simvastatin is part of an ongoing FDA effort to evaluate the risk of statin-associated muscle injury and to provide that information to the public as it becomes available," said Eric Colman, M.D., Deputy Director of FDA's Division of Metabolism and Endocrinology Products (DMEP). "It's important for patients and healthcare professionals to consider all the potential risks and known benefits of any drug before deciding on any one therapy or dose of therapy."

Simvastatin is sold as a single-ingredient generic medication and as the brand-name Zocor. It also is sold in combination with ezetimibe as Vytorin, and in combination with niacin as Simcor.

FDA's review of new information on the risk of muscle injury is derived from clinical trials, observational studies, adverse event reports, and prescription use data. The agency also is reviewing data from the SEARCH (Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine) trial, which evaluated major cardiovascular events, such as heart attack, re-vascularization and cardiovascular death, in patients taking 80 mg compared to 20 mg of simvastatin. SEARCH also included data on muscle injury in patients taking simvastatin.

FDA is committed to informing the public about its ongoing safety review of drugs and will update the public as soon as the review of simvastatin is complete.

For further information on this safety issue

Ongoing Safety Review of High-dose Zocor (simvastatin) and Increased Risk of Muscle Injury

www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm204882.htm

For previous FDA safety communications on the increased risk of muscle injury with simvastatin in patients who concurrently take other medications:

www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm118869.htm

Similar Topics

1 : FDA Restricts Sale and Distribution of Essure : U.S. Food and Drug Administration (FDA).
2 : FDA Warns About Illegal Use of Injectable Silicone for Body Contouring and Associated Health Risks : U.S. Food and Drug Administration (FDA).
3 : FDA Warning: Potential Contamination in Multiple Brands Of Drugs, Dietary Supplements : U.S. Food and Drug Administration.
4 : FDA Warning: Elevated Levels of Belladonna in Certain Homeopathic Teething Products : U.S. Food and Drug Administration.
5 : Laundry Detergent Pods Pose Deadly Risk for Children : Nationwide Children's Hospital.
From our Recalls and Advisory Alerts section - Full List (77 Items)


Submit disability news, coming events, as well as assistive technology product news and reviews.


Loan Information for low income singles, families, seniors and disabled. Includes home, vehicle and personal loans.


Famous People with Disabilities - Well known people with disabilities and conditions who contributed to society.


List of awareness ribbon colors and their meaning. Also see our calendar of awareness dates.


Blood Pressure Chart - What should your blood pressure be, and information on blood group types/compatibility.





1 : Bias Keeps Women with Higher Body Weight Away From the Doctor
2 : Smart Hoteliers are Building a Healthier Future
3 : Teaching Baby Sign Language - Nita, Show Us More
4 : MitoQ Novel Antioxidant Makes Old Arteries Seem Young Again
5 : Telemedicine Helps Overcome Healthcare Gender Based Barriers
6 : Screen Reader Plus Keyboard Helps Blind, Low-Vision Users Browse Modern Webpages
7 : Our Digital Remains Should be Treated with Same Care and Respect as Physical Remains
8 : Tungsten: Concern Over Possible Health Risk by Human Exposure to Tungsten


Disclaimer: This site does not employ and is not overseen by medical professionals. Content on Disabled World is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. See our Terms of Service for more information.

Reporting Errors: Disabled World is an independent website, your assistance in reporting outdated or inaccurate information is appreciated. If you find an error please let us know.

© 2004 - 2018 Disabled World™